Patents by Inventor Jewel Payne

Jewel Payne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5753492
    Abstract: This invention concerns genes or gene fragments which have been cloned from novel Bacillus thuringiensis isolates which have nematicidal activity. These genes or gene fragments can be used to transform suitable hosts for controlling nematodes.
    Type: Grant
    Filed: September 30, 1994
    Date of Patent: May 19, 1998
    Assignee: Mycogen Corporation
    Inventors: H. Ernest Schnepf, George E. Schwab, Jewel Payne, Kenneth E. Narva, Luis Foncerrada
  • Patent number: 5723758
    Abstract: Novel B.t. genes encoding toxins active against lepidopteran insects have been cloned from a novel lepidopteran-active B. thuringiensis microbe. The DNA encoding the B.t. toxin can be used to transform various hosts to express the B.t. toxin.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: March 3, 1998
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, David A. Cummings, Raymond J.C. Cannon, Kenneth E. Narva, Steve Stelman
  • Patent number: 5691308
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: December 14, 1994
    Date of Patent: November 25, 1997
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 5686069
    Abstract: Disclosed and claimed are novel Bacillus thuringiensis isolates which have lepidopteran activity. Thus, these isolates, or mutants thereof, can be used to control such insect pests. Further, genes encoding novel .delta.-endotoxins can be removed from the isolates and transferred to other host microbes, or plants. Expression of the .delta.-endotoxins in such hosts results in the control of susceptible insect pests in the environment of such hosts.
    Type: Grant
    Filed: August 15, 1994
    Date of Patent: November 11, 1997
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick, Kenneth E. Narva, H. Ernest Schnepf, George E. Schwab
  • Patent number: 5635480
    Abstract: Disclosed and claimed are toxins produced by novel Bacillus thuringiensis isolates designated B.t. PS92J, B.t. PS196S1, B.t. PS201L1, and B.t. PS201T6, which have dipteran and/or corn rootworm activity. Thus, the isolates, or mutants thereof, can be used to control such pests. Further, claimed are novel genes encoding these .delta.-endotoxins, which can be expressed in other hosts. Expression of the .delta.-endotoxins in such hosts results in the control of susceptible insect pests in the environment of such hosts.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: June 3, 1997
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, Kenneth E. Narva, Kendrick A. Uyeda, Christine J. Stalder, Tracy E. Michaels
  • Patent number: 5632987
    Abstract: Disclosed and claimed are toxins and genes from Bacillus thuringiensis strains designated PS80JJ1, PS158D5, PS167P, PS169E, PS177F1, PS177G, PS204G4, PS204G6 which can be used to control corn rootworm. Mutants which retain the activity of the parent strain can be used to control the pest. Further, isolated spores or purified toxins from these isolates can be used to control corn rootworm. Genes encoding .delta.-endotoxins can be removed from these strains using standard well-known techniques, and transferred to other hosts. Expression of the .delta.-endotoxin in such hosts results in control of corn rootworm larvae.
    Type: Grant
    Filed: December 16, 1994
    Date of Patent: May 27, 1997
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, Kenneth E. Narva
  • Patent number: 5589382
    Abstract: Novel B.t. genes encoding toxins active against nematode pests have been cloned. The DNA encoding the B.t. toxin can be used to transform various hosts to express the B.t. toxin.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 31, 1996
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, Kenneth E. Narva, Jenny Fu
  • Patent number: 5521286
    Abstract: A novel B.t. toxin gene toxic to lepidopteran insects has been cloned from a novel lepidopteran-active B. thuringiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: July 20, 1994
    Date of Patent: May 28, 1996
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 5436002
    Abstract: Disclosed and claimed are toxins produced by novel Bacillus thuringiensis isolates designated B.t. PS92J, B.t. PS196S1, B.t. PS201L1, and B.t. PS201T6, which have dipteran and/or corn rootworm activity. Thus, the isolates, or mutants thereof, can be used to control such pests. Further, claimed are novel genes encoding these .delta.-endotoxins, which can be expressed in other hosts. Expression of the .delta.-endotoxins in such hosts results in the control of susceptible insect pests in the environment of such hosts.
    Type: Grant
    Filed: September 30, 1993
    Date of Patent: July 25, 1995
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, Kenneth E. Narva, Kendrick A. Uyeda, Christine J. Stalder, Tracy E. Michaels
  • Patent number: 5407825
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: March 29, 1993
    Date of Patent: April 18, 1995
    Assignee: Mycogen Corp.
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 5352661
    Abstract: A novel B.t. isolate with activity against lepidopteran insects is disclosed. This isolate is highly active against the beet armyworm. A gene from this isolate has been cloned. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: July 27, 1992
    Date of Patent: October 4, 1994
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick, Mark Thompson
  • Patent number: 5350576
    Abstract: Disclosed are Bacillus thuringiensis isolates designated B.t. PS45B1, B.t. PS24J, B.t. PS94R3 B.t. PS17, B.t. PS62B1 and B.t. PS74G1 which produce novel .delta.-endotoxins active against acarid pests. Thus, these isolates, or mutants thereof, can be used to control such pests. Claimed are genes encoding these novel .delta.-endotoxins, which can be removed from these isolates and transferred to other host microbes, or plants. Expression of the toxins in microbe hosts results in the control of acarid pests, whereas transformed plants become resistant to acarid pests.
    Type: Grant
    Filed: May 17, 1993
    Date of Patent: September 27, 1994
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, Raymond J. C. Cannon, Angela L. Ralph
  • Patent number: 5336492
    Abstract: A novel B.t. toxin gene toxic to lepidopteran insects has been cloned from a novel lepidopteran-active B. thuringiensis microbe, The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: November 17, 1993
    Date of Patent: August 9, 1994
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 5296368
    Abstract: A novel B.t. toxin gene toxic to lepidopteran insects has been cloned from a novel lepidopteran-active B. thuringiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: November 19, 1992
    Date of Patent: March 22, 1994
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 5246852
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: June 12, 1991
    Date of Patent: September 21, 1993
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 5206166
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: June 25, 1992
    Date of Patent: April 27, 1993
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 5188960
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: December 14, 1989
    Date of Patent: February 23, 1993
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 5169629
    Abstract: A novel B.t. isolate with activity against lepidopteran insects is disclosed. This isolate is highly active agaist the beet armyworm. A gene from this isolate has been cloned. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: November 1, 1988
    Date of Patent: December 8, 1992
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick, Mark Thompson
  • Patent number: 5164180
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: December 14, 1989
    Date of Patent: November 17, 1992
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 5135867
    Abstract: A novel B.t. isolate with activity against lepidopteran insects is disclosed. This isolate is highly active against the beet armyworm. A gene from this isolate has been cloned. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: November 16, 1990
    Date of Patent: August 4, 1992
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick, Mark Thompson